EPI2ME end-to-end workflows for biopharma quality control of plasmids and mRNA
)
- Published on: May 20 2025
)
Sample preparation, bespoke basecalling, and medaka models, the Q-Line GridION device and EPI2ME analysis workflows are revolutionising quality control in biopharma.
Download the poster to find out:
- How Oxford Nanopore end-to-end workflows could replace traditional QC methods
- More about what GridION Q offers when it comes to QC assays
- About the plasmid QC workflow
- About the mRNA QC workflow for mRNA products, such as vaccines
